For millennials and Gen Z, cancer is no longer rare. Once considered something people get as they grow older, it’s become a ...
The former Illinois governor has been undergoing chemotherapy after a diagnosis last month, he told the Sun-Times. “I’m ...
Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...
DURIPANC is an investigator-initiated, exploratory, open-label, single-center study in the Netherlands at the Erasmus Medical ...
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to come.As few as one in ten people survive pancreatic cancer five years after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results